Knockdown of TRPM8 in bladder cancer cells decreases p-AKT and increases p-GSK-3β level, which alters the process regulated by the AKT/GSK-3β signaling (Wang et al., 2020). This evidence concerns the gene GSK3B and urinary bladder cancer.